<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="37647">Xanthones</z:chebi> are a group of oxygen-containing <z:chebi fb="0" ids="5686">heterocyclic compounds</z:chebi> with remarkable pharmacological effects such as anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, anti-inflammatory, and antimicrobial activities </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A <z:chebi fb="0" ids="37647">xanthones</z:chebi> extract (81% α-mangostin and 16% γ-mangostin), was prepared by crystallization of a <z:chebi fb="9" ids="17578">toluene</z:chebi> extract of G. mangostana fruit <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">rinds</z:e> and was analyzed by LC-MS </plain></SENT>
<SENT sid="2" pm="."><plain>Anti-<z:hpo ids='HP_0003003'>colon cancer</z:hpo> effect was investigated on HCT 116 human colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells including cytotoxicity, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, anti-tumorigenicity, and effect on cell signalling pathways </plain></SENT>
<SENT sid="3" pm="."><plain>The in vivo anti-<z:hpo ids='HP_0003003'>colon cancer</z:hpo> activity was also investigated on subcutaneous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> established in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The extract showed potent cytotoxicity (median inhibitory concentration 6.5 ± 1.0 μg/ml), due to induction of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathway of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Three key steps in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> including the cell migration, cell invasion and clonogenicity, were also inhibited </plain></SENT>
<SENT sid="6" pm="."><plain>The extract and α-mangostin up-regulate the MAPK/ERK, c-Myc/Max, and p53 cell signalling pathways </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:chebi fb="0" ids="37647">xanthones</z:chebi> extract, when fed to <z:mp ids='MP_0003815'>nude</z:mp> mice, caused significant growth inhibition of the subcutaneous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> of HCT 116 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Our data suggest new mechanisms of action of α-mangostin and the G. mangostana <z:chebi fb="0" ids="37647">xanthones</z:chebi>, and suggest the <z:chebi fb="0" ids="37647">xanthones</z:chebi> extract of as a potential anti-<z:hpo ids='HP_0003003'>colon cancer</z:hpo> candidate </plain></SENT>
</text></document>